Post 2023
-
Clinical Year in Review Begins with Latest Developments in ARDS, Pulmonary Vascular Disease, COPD, ILD
The first of four Clinical Year in Review sessions highlighted the latest papers published on acute respiratory distress syndrome, pulmonary vascular disease, chronic obstructive pulmonary disease, and interstitial lung disease. Stephanie Christenson, MD, MS, discussed new approaches to change the course of COPD recommended by the Lancet Commission and incorporated into the 2023 GOLD Report.
-
Experts Discuss Impactful Papers on Lung Cancer, COVID-19, Palliative Care, and Critical Care in Second Clinical Year in Review
The second session of the Clinical Year in Review explored the latest developments in lung cancer, COVID-19, palliative care, and critical care. Tiffanie Jones, MD, MPH, MSCE, discussed how early mobilization of patients in the intensive care unit affects ICU-acquired weaknesses.
-
International Respiratory Societies Gather to Discuss Inequities in COPD Treatment
The Respiratory Societies of the Americas kicked off its first in-person session at the ATS 2023 International Conference with representatives from four societies discussing COPD, its effects on country-specific populations, and the impact of health policies in relation to COPD. In Brazil, COPD is present in 6 percent of deaths, reported Frederico Fernandes, MD, PhD.
-
President’s Forum Focuses on Early Life Antecedents of Adult Lung Disease
Experts convened to explain the importance of early detection of prenatal and childhood respiratory illnesses and exposure to possible factors that could lead to adult respiratory disease. Some of these factors include airborne pollutants, viral infections like asthma, small airways disease, and COPD. Preterm birth exacerbates problems with pulmonary function across the lifespan, explained Kara…